Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept study
This study is completed. It focuses on ADHD and currently lists study information in the Netherlands and Switzerland.
Multiple locations, including Maastricht
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on ADHD and currently lists study information in the Netherlands and Switzerland.
Multiple locations, including MaastrichtThis study is completed. It focuses on ADHD and currently lists study information in Russian Federation.
Multiple locations, including YekaterinburgThis study is completed. It focuses on schizophrenia and currently lists study information in Japan, South Korea, and Taiwan.
Multiple locations, including SapporoThis study is completed. It focuses on ADHD and currently lists study information in Global.
In GlobalThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
Multiple locations, including EncinoThis study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including Little RockThis study has public registry information. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including Little RockThis study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including Little RockThis study is completed. It focuses on ADHD and currently lists study information in Global.
In GlobalThis study is completed. It focuses on ADHD and currently lists study information in Global.
In GlobalThis study is completed. It focuses on schizophrenia and currently lists study information in South Korea.
In JeonjuThis study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including Little Rock